Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma Clinical Trials

5 clinical trials for Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis — RECRUITING · PHASE2
• Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer — RECRUITING · PHASE2
• A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE1
• Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases — NOT_YET_RECRUITING · PHASE3
• AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2) — NOT_YET_RECRUITING

Refine this search